Mereo BioPharma Group plc PDMR Shareholding (8341Z)

TIDMMPH

RNS Number : 8341Z

Mereo BioPharma Group plc

22 May 2019

Mereo BioPharma Group plc

("Mereo" or the "Company")

Notification of PDMR Dealing

London, May 22, 2019 - Mereo BioPharma Group plc (AIM: MPH, NASDAQ: MREO), a clinical stage UK based biopharmaceutical company focused on rare diseases, received notification that on May 20, 2019, Alexandra ("Wills") Hughes-Wilson, Head of Patient Access & Commercial Planning at Mereo, purchased 1,650 American Depositary Shares (ADSs) at a price of USD5.42 per share.

The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.

 
 1    Details of the person discharging managerial responsibilities 
 a)   Name                      Alexandra ("Wills") Hughes-Wilson 
     ------------------------  ---------------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------------ 
 a)   Position/status           Head of Patient Access & Commercial Planning, 
                                 Mereo BioPharma Group plc 
     ------------------------  ---------------------------------------------- 
 b)   Initial notification/     Initial notification 
       Amendment 
     ------------------------  ---------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------ 
 a)   Name                      Mereo BioPharma Group plc 
     ------------------------  ---------------------------------------------- 
 b)   LEI                       213800U8JQHIJOS5AS09 
     ------------------------  ---------------------------------------------- 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ------------------------------------------------------------------------ 
 a)   Description of            MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY 
       the financial             SHARES (ADSs) 
       instrument, type 
       of instrument 
       and identification 
       code 
     ------------------------  ---------------------------------------------- 
 b)   Nature of the             PURCHASE of ADSs 
       transaction 
     ------------------------  ---------------------------------------------- 
 c)   Price(s) and                Price(s)    Volume(s) 
       volume(s)                   USD5.42     1,650 
                                              ---------- 
     ------------------------  ---------------------------------------------- 
 d)   Aggregated information:   Aggregated volume: 1,650 
       volume, Price             Aggregated price: USD5.42 
     ------------------------  ---------------------------------------------- 
 e)   Date of the transaction   2019-05-20 
     ------------------------  ---------------------------------------------- 
 f)   Place of the              XNMS 
       transaction 
     ------------------------  ---------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHGIGDUIDDBGCD

(END) Dow Jones Newswires

May 22, 2019 04:45 ET (08:45 GMT)